v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenue        
Revenue $ 55,089 $ 22,574 $ 117,974 $ 22,589
Operating expenses:        
Cost of Revenue 39,019 10,060 86,120 10,070
Research and development 208,599 149,163 580,731 419,837
Selling, general and administrative 85,568 45,018 223,683 105,497
Total operating expenses 333,186 204,241 890,534 535,404
Loss from operations (278,097) (181,667) (772,560) (512,815)
Interest and other income, net 16,732 9,673 53,445 29,420
Loss on common stock issuance in private placement 0 0 0 (40,258)
Gain (loss) from change in fair value of warrants, earnout shares and contingent consideration, net 49,765 (229,149) 152,432 (284,424)
Total other income (loss), net 66,497 (219,476) 205,877 (295,262)
Loss before income taxes (211,600) (401,143) (566,683) (808,077)
Income tax expense 230 83 540 229
Net loss $ (211,830) $ (401,226) $ (567,223) $ (808,306)
Net loss per share, basic (in dollars per share) $ (0.22) $ (0.48) $ (0.59) $ (1.01)
Net loss per share, diluted (in dollars per share) $ (0.22) $ (0.48) $ (0.59) $ (1.01)
Weighted-average common stock outstanding, basic (in shares) 978,533,969 844,551,006 964,109,268 803,188,296
Weighted-average common stock outstanding, diluted (in shares) 978,533,969 844,551,006 964,109,268 803,188,296